worldUpdated: May 30, 2020 20:29 ISTA Covid-19 vaccine under development in China could be in the market by the end of the year, a government body affiliated to the country’s cabinet, the State Council, has announced. More than 2000 people have received the vaccine in the first two phases of the trial. The announcement added that data from the two first two phases of clinical trials show that the candidate vaccine’s safety and efficacy were better than other vaccines under development. More than 100 vaccines for the virus are being developed globally, and in China, a total of five vaccines are being developed and tested on humans. Meanwhile, Wuhan is set to complete the ambitious task of conducting nucleic acid tests (NAT) on all its residents to check for asymptomatic patients.

Source: Hindustan Times May 30, 2020 14:58 UTC